 | • レポートコード：MRC2304F249 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、254ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本市場調査資料では、世界の臨床リスクグループ化ソリューション市場規模が、2021年に716.86百万ドル、2022年に813.94百万ドルになり、その後CAGR 13.71％で成長して2027年までに1,550.33百万ドルに達すると予測しています。本書は、臨床リスクグループ化ソリューションの世界市場を対象とした調査・分析結果をまとめたものであり、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別分析（ダッシュボード分析ソリューション、リスク報告ソリューション、スコアカード＆視覚化ツール）、展開別分析（プライベートクラウド、パブリッククラウド）、エンドユーザー別分析（外来診療センター、病院、長期療養センター、支払者）、地域別分析（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）、競争状況、企業情報などの内容を掲載しています。なお、本書内の企業情報には、3M Company、4S Information Systems Ltd.、Cerner Corporation、Conduent Incorporated、Dynamic Healthcare Systems, Inc.、Evolent Health、HBI Solutions, Inc.、Health Catalyst Inc.、Johns Hopkins University、Lightbeam Health Solutions, LLCなどが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の臨床リスクグループ化ソリューション市場規模：製品別 - ダッシュボード分析ソリューションの市場規模 - リスク報告ソリューションの市場規模 - スコアカード＆視覚化ツールの市場規模 ・世界の臨床リスクグループ化ソリューション市場規模：展開別 - プライベートクラウドの市場規模 - パブリッククラウドの市場規模 ・世界の臨床リスクグループ化ソリューション市場規模：エンドユーザー別 - 外来診療センターにおける市場規模 - 病院における市場規模 - 長期療養センターにおける市場規模 - 支払者における市場規模 ・世界の臨床リスクグループ化ソリューション市場規模：地域別 - 南北アメリカの臨床リスクグループ化ソリューション市場規模 アメリカの臨床リスクグループ化ソリューション市場規模 カナダの臨床リスクグループ化ソリューション市場規模 ブラジルの臨床リスクグループ化ソリューション市場規模 ... - アジア太平洋の臨床リスクグループ化ソリューション市場規模 日本の臨床リスクグループ化ソリューション市場規模 中国の臨床リスクグループ化ソリューション市場規模 インドの臨床リスクグループ化ソリューション市場規模 韓国の臨床リスクグループ化ソリューション市場規模 台湾の臨床リスクグループ化ソリューション市場規模 ... - ヨーロッパ/中東/アフリカの臨床リスクグループ化ソリューション市場規模 イギリスの臨床リスクグループ化ソリューション市場規模 ドイツの臨床リスクグループ化ソリューション市場規模 フランスの臨床リスクグループ化ソリューション市場規模 ロシアの臨床リスクグループ化ソリューション市場規模 ... - その他地域の臨床リスクグループ化ソリューション市場規模 ・競争状況 ・企業情報 |
The Global Clinical Risk Grouping Solution Market size was estimated at USD 716.86 million in 2021 and expected to reach USD 813.94 million in 2022, and is projected to grow at a CAGR 13.71% to reach USD 1,550.33 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Clinical Risk Grouping Solution to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across Dashboard Analytics Solutions, Risk Reporting Solutions, and Scorecards & Visualization Tools.
Based on Deployment Mode, the market was studied across Private Cloud and Public Cloud.
Based on End User, the market was studied across Ambulatory Care Centers, Hospitals, Long-Term Care Centers, and Payers.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Clinical Risk Grouping Solution market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Clinical Risk Grouping Solution Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Clinical Risk Grouping Solution Market, including 3M Company, 4S Information Systems Ltd., Cerner Corporation, Conduent Incorporated, Dynamic Healthcare Systems, Inc., Evolent Health, HBI Solutions, Inc., Health Catalyst Inc., Johns Hopkins University, Lightbeam Health Solutions, LLC, Nuance Communications, Optum Inc., and Perahealth, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Clinical Risk Grouping Solution Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Clinical Risk Grouping Solution Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Clinical Risk Grouping Solution Market?
4. What is the competitive strategic window for opportunities in the Global Clinical Risk Grouping Solution Market?
5. What are the technology trends and regulatory frameworks in the Global Clinical Risk Grouping Solution Market?
6. What is the market share of the leading vendors in the Global Clinical Risk Grouping Solution Market?
7. What modes and strategic moves are considered suitable for entering the Global Clinical Risk Grouping Solution Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing focus on patient’s risk management
5.1.1.2. Implementation of big data in the healthcare industry to transform clinical outcomes
5.1.1.3. Advantages of risk management solutions
5.1.2. Restraints
5.1.2.1. Lack of infrastructure coupled with capital intensive clinical solutions
5.1.3. Opportunities
5.1.3.1. Increasing focus on AI and machine learning
5.1.3.2. Adoption of recording and maintaining the health records
5.1.3.3. Increasing physician burnout due to documentation needs
5.1.4. Challenges
5.1.4.1. Patient data privacy concerns
5.2. Cumulative Impact of COVID-19
6. Clinical Risk Grouping Solution Market, by Product
6.1. Introduction
6.2. Dashboard Analytics Solutions
6.3. Risk Reporting Solutions
6.4. Scorecards & Visualization Tools
7. Clinical Risk Grouping Solution Market, by Deployment Mode
7.1. Introduction
7.2. Private Cloud
7.3. Public Cloud
8. Clinical Risk Grouping Solution Market, by End User
8.1. Introduction
8.2. Ambulatory Care Centers
8.3. Hospitals
8.4. Long-Term Care Centers
8.5. Payers
9. Americas Clinical Risk Grouping Solution Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Clinical Risk Grouping Solution Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Clinical Risk Grouping Solution Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. 3M Company
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. 4S Information Systems Ltd.
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Cerner Corporation
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Conduent Incorporated
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Dynamic Healthcare Systems, Inc.
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Evolent Health
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. HBI Solutions, Inc.
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Health Catalyst Inc.
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Johns Hopkins University
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Lightbeam Health Solutions, LLC
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Nuance Communications
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Optum Inc.
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Perahealth, Inc.
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing